Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Misoprostol vs Oxytocin with Mechanical Dilation for High-risk Pregnancy Inductions
NCT04492072Completed
- Sponsor
- Thomas Jefferson University
- Start
- Aug 2020
- Primary completion
- May 2022
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, open-label trial of oxytocin (2 arms), sponsored by Thomas Jefferson University. Primary endpoint: Rate of Cesarean Delivery at 48 hours. Started Aug 2020; status: completed.
02
Drugs
oxytocin
Beyond the preview
Go deeper on NCT04492072.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04492072.